查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1467816

2024-2032 年骨关节炎治疗市场报告（依解剖类型、药物类型、给药途径、配销通路和地区）

Osteoarthritis Therapeutics Market Report by Anatomy Type, Drug Type, Route of Administration, Distribution Channel, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 137 Pages | 商品交期: 2-3个工作天内

价格

IMARC Group年，全球骨关节炎治疗市场规模达79亿美元。

骨关节炎 (OA) 是一种异质性疾病，其特征是膝盖、臀部、手、脚、脊椎、肩膀和颈部关节的软骨进行性退化。骨关节炎通常会导致僵硬、肿胀、压痛、持续疼痛、失去灵活性、刺痛感、骨刺和睡眠障碍。可以透过身体检查、X 光、关节镜检查、关节液分析、血液检查和磁振造影 (MRI) 扫描来诊断。根据不同的结果开立各种药物和手术程序来减轻疾病的征兆和症状。目前，市面上有替代药物、物理治疗和支持装置来缓解疼痛和改善关节功能。

全球骨关节炎治疗市场趋势与驱动因素：

久坐的生活方式、不健康的饮食模式以及肥胖和血糖盛行率的上升正在增加个体患骨关节炎的风险。这与日益增长的老年人口（更容易患此类疾病）相结合，是推动骨关节炎治疗市场成长的关键因素之一。除此之外，易于取得核磁共振扫描是另一个主要的生长诱导因素。此外，基于放射学特征的成像生物标记的开发，加上镇痛药物的引入，正在促进市场的成长。此外，为推出新的诊断方法和生物标记而对研发（R＆D）活动的​​投资不断增加，以及改善医疗基础设施的支出不断增加，也正在推动市场发展。例如，疾病缓解药物正在开发中，其重点是促发炎细胞因子来治疗软骨损伤。

本报告回答的关键问题

  • 2023年全球骨关节炎治疗市场规模有多大？
  • 2024-2032年全球骨关节炎治疗市场的预期成长率是多少？
  • 推动全球骨关节炎治疗市场的关键因素是什么？
  • COVID-19 对全球骨关节炎治疗市场有何影响？
  • 根据解剖类型，全球骨关节炎治疗市场的细分如何？
  • 根据药物类型，全球骨关节炎治疗市场的细分如何？
  • 根据给药途径，全球骨关节炎治疗市场的细分如何？
  • 基于配销通路的全球骨关节炎治疗市场的细分情况如何？
  • 全球骨关节炎治疗市场的关键地区有哪些？
  • 谁是全球骨关节炎治疗市场的主要参与者/公司？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球骨关节炎治疗市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：依解剖类型

  • 膝盖
    • 市场走向
    • 市场预测
  • 时髦的
    • 市场走向
    • 市场预测
  • 手
    • 市场走向
    • 市场预测
  • 脊椎
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 7 章：市场区隔：按药物类型

  • 非类固醇抗发炎药
    • 市场走向
    • 市场预测
  • 止痛药
    • 市场走向
    • 市场预测
  • 皮质类固醇
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 8 章：市场区隔：依管理途径

  • 注射用
    • 市场走向
    • 市场预测
  • 专题
    • 市场走向
    • 市场预测
  • 口服
    • 市场走向
    • 市场预测

第 9 章：市场区隔：按配销通路

  • 医院
    • 市场走向
    • 市场预测
  • 专科诊所
    • 市场走向
    • 市场预测
  • 医疗机构
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 10 章：市场区隔：按地区

  • 北美洲
    • 美国
      • 市场走向
      • 市场预测
    • 加拿大
      • 市场走向
      • 市场预测
  • 亚太地区
    • 中国
      • 市场走向
      • 市场预测
    • 日本
      • 市场走向
      • 市场预测
    • 印度
      • 市场走向
      • 市场预测
    • 韩国
      • 市场走向
      • 市场预测
    • 澳洲
      • 市场走向
      • 市场预测
    • 印尼
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 欧洲
    • 德国
      • 市场走向
      • 市场预测
    • 法国
      • 市场走向
      • 市场预测
    • 英国
      • 市场走向
      • 市场预测
    • 义大利
      • 市场走向
      • 市场预测
    • 西班牙
      • 市场走向
      • 市场预测
    • 俄罗斯
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场走向
      • 市场预测
    • 墨西哥
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 中东和非洲
    • 市场走向
    • 市场细分：按国家/地区
    • 市场预测

第 11 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 12 章：价值链分析

第 13 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 14 章：价格分析

第15章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Abbott Laboratories
    • Anika Therapeutics Inc.
    • Bayer Aktiengesellschaft
    • Eli Lilly and Company
    • Flexion Therapeutics Inc.
    • GlaxoSmithKline Plc
    • Horizon Therapeutics Plc
    • Johnson & Johnson Inc.
    • Pfizer Inc.
    • Sanofi SA
Product Code: SR112024A2791

The global osteoarthritis therapeutics market size reached US$ 7.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 15.0 Billion by 2032, exhibiting a growth rate (CAGR) of 7.1% during 2024-2032.

Osteoarthritis (OA) is a heterogeneous condition characterized by progressive degeneration of cartilage in joints of the knees, hips, hands, feet, spine, shoulders and neck. OA generally leads to stiffness, swelling, tenderness, persistent pain, loss of flexibility, grating sensation, bone spurs and sleep disturbances. It can be diagnosed using physical examination, X-ray, arthroscopy, joint fluid analysis, blood tests and magnetic resonance imaging (MRI) scan. Various medications and surgical procedures are prescribed as per the different results to alleviate the signs and symptoms of the disease. Currently, alternative medicines, physical therapies and supportive devices are available in the market to relieve pain and improve joint function.

Global Osteoarthritis Therapeutics Market Trends and Drivers:

Sedentary lifestyles, unhealthy dietary patterns and the rising prevalence of obesity and blood sugar are increasing the risk of developing OA among individuals. This, in confluence with the growing geriatric population, which is more susceptible to such ailments, represents one of the key factors impelling the osteoarthritis therapeutics market growth. Apart from this, the easy access to MRI scans is acting as another major growth-inducing factor. Additionally, the development of imaging biomarkers based on radiographic features, coupled with the introduction of analgesic drugs, is contributing to the market growth. Furthermore, rising investments in the research and development (R&D) activities to launch new diagnostics and biomarkers, along with the increasing expenditures on improving healthcare infrastructure, is also driving the market. For instance, disease-modifying drugs are under development, which focus on proinflammatory cytokines for treating cartilage breakdown.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global osteoarthritis therapeutics market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on anatomy type, drug type, route of administration and distribution channel.

Breakup by Anatomy Type:

Knee

Hip

Hand

Spine

Others

Breakup by Drug Type:

Nonsteroidal Anti-Inflammatory Drugs

Analgesics

Corticosteroids

Others

Breakup by Route of Administration:

Parenteral

Topical

Oral

Breakup by Distribution Channel:

Hospitals

Specialty Clinics

Medical Institutions

Others

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, Anika Therapeutics Inc., Bayer Aktiengesellschaft, Eli Lilly and Company, Flexion Therapeutics Inc., GlaxoSmithKline Plc, Horizon Therapeutics Plc, Johnson & Johnson Inc., Pfizer Inc. and Sanofi S.A.

Key Questions Answered in This Report

  • 1. What was the size of the global osteoarthritis therapeutics market in 2023?
  • 2. What is the expected growth rate of the global osteoarthritis therapeutics market during 2024-2032?
  • 3. What are the key factors driving the global osteoarthritis therapeutics market?
  • 4. What has been the impact of COVID-19 on the global osteoarthritis therapeutics market?
  • 5. What is the breakup of the global osteoarthritis therapeutics market based on the anatomy type?
  • 6. What is the breakup of the global osteoarthritis therapeutics market based on the drug type?
  • 7. What is the breakup of the global osteoarthritis therapeutics market based on the route of administration?
  • 8. What is the breakup of the global osteoarthritis therapeutics market based on the distribution channel?
  • 9. What are the key regions in the global osteoarthritis therapeutics market?
  • 10. Who are the key players/companies in the global osteoarthritis therapeutics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Osteoarthritis Therapeutics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Anatomy Type

  • 6.1 Knee
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Hip
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Hand
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Spine
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Drug Type

  • 7.1 Nonsteroidal Anti-Inflammatory Drugs
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Analgesics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Corticosteroids
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Route of Administration

  • 8.1 Parenteral
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Topical
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Oral
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Distribution Channel

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Specialty Clinics
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Medical Institutions
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abbott Laboratories
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Anika Therapeutics Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Bayer Aktiengesellschaft
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Eli Lilly and Company
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Flexion Therapeutics Inc.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
    • 15.3.6 GlaxoSmithKline Plc
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Horizon Therapeutics Plc
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Johnson & Johnson Inc.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Pfizer Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Sanofi S.A
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Osteoarthritis Therapeutics Market: Major Drivers and Challenges
  • Figure 2: Global: Osteoarthritis Therapeutics Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Osteoarthritis Therapeutics Market: Breakup by Anatomy Type (in %), 2023
  • Figure 4: Global: Osteoarthritis Therapeutics Market: Breakup by Drug Type (in %), 2023
  • Figure 5: Global: Osteoarthritis Therapeutics Market: Breakup by Route of Administration (in %), 2023
  • Figure 6: Global: Osteoarthritis Therapeutics Market: Breakup by Distribution Channel (in %), 2023
  • Figure 7: Global: Osteoarthritis Therapeutics Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 9: Global: Osteoarthritis Therapeutics (Knee) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Osteoarthritis Therapeutics (Knee) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Osteoarthritis Therapeutics (Hip) Market: Sales Value (in Million US$), 2018 & 2023

Figure 12 Global: Osteoarthritis Therapeutics (Hip) Market Forecast: Sales Value (in Million US$), 2024-2032

  • Figure 13: Global: Osteoarthritis Therapeutics (Hand) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Osteoarthritis Therapeutics (Hand) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Osteoarthritis Therapeutics (Spine) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Osteoarthritis Therapeutics (Spine) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Osteoarthritis Therapeutics (Other Anatomy Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Osteoarthritis Therapeutics (Other Anatomy Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Osteoarthritis Therapeutics (Nonsteroidal Anti-Inflammatory Drugs) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Osteoarthritis Therapeutics (Nonsteroidal Anti-Inflammatory Drugs) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Osteoarthritis Therapeutics (Analgesics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Osteoarthritis Therapeutics (Analgesics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Osteoarthritis Therapeutics (Corticosteroids) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Osteoarthritis Therapeutics (Corticosteroids) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Osteoarthritis Therapeutics (Other Drug Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Osteoarthritis Therapeutics (Other Drug Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Osteoarthritis Therapeutics (Parenteral) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Osteoarthritis Therapeutics (Parenteral) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Osteoarthritis Therapeutics (Topical) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Osteoarthritis Therapeutics (Topical) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Osteoarthritis Therapeutics (Oral) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Osteoarthritis Therapeutics (Oral) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Osteoarthritis Therapeutics (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Osteoarthritis Therapeutics (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: Osteoarthritis Therapeutics (Specialty Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: Osteoarthritis Therapeutics (Specialty Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Global: Osteoarthritis Therapeutics (Medical Institutions) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Global: Osteoarthritis Therapeutics (Medical Institutions) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Global: Osteoarthritis Therapeutics (Other Distribution Channels) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Global: Osteoarthritis Therapeutics (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: North America: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: North America: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: United States: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: United States: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Canada: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Canada: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Asia Pacific: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Asia Pacific: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: China: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: China: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Japan: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Japan: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: India: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: India: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: South Korea: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: South Korea: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Australia: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Australia: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Indonesia: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Indonesia: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Others: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Others: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Europe: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Europe: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Germany: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Germany: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: France: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: France: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: United Kingdom: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: United Kingdom: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Italy: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Italy: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Spain: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Spain: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Russia: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Russia: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Others: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Others: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Latin America: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Latin America: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Brazil: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: Brazil: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: Mexico: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 84: Mexico: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 85: Others: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 86: Others: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 87: Middle East and Africa: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 88: Middle East and Africa: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 89: Global: Osteoarthritis Therapeutics Industry: SWOT Analysis
  • Figure 90: Global: Osteoarthritis Therapeutics Industry: Value Chain Analysis
  • Figure 91: Global: Osteoarthritis Therapeutics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Osteoarthritis Therapeutics Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Osteoarthritis Therapeutics Market Forecast: Breakup by Anatomy Type (in Million US$), 2024-2032
  • Table 3: Global: Osteoarthritis Therapeutics Market Forecast: Breakup by Drug Type (in Million US$), 2024-2032
  • Table 4: Global: Osteoarthritis Therapeutics Market Forecast: Breakup by Route of Administration (in Million US$), 2024-2032
  • Table 5: Global: Osteoarthritis Therapeutics Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
  • Table 6: Global: Osteoarthritis Therapeutics Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Osteoarthritis Therapeutics Market: Competitive Structure
  • Table 8: Global: Osteoarthritis Therapeutics Market: Key Players